![](/img/cover-not-exists.png)
The Impact of Price Reductions After Loss of Exclusivity in a Cost-Effectiveness Analysis: Fingolimod Versus Interferon Beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis
Hua, Le H., Hersh, Carrie M., Morten, Peter, Kusel, Jeanette, Lin, Feng, Cave, Julie, Varga, Stefan, Herrera, Vivian, Ko, John J.Volume:
25
Language:
english
Journal:
Journal of Managed Care & Specialty Pharmacy
DOI:
10.18553/jmcp.2019.25.4.490
Date:
April, 2019
File:
PDF, 339 KB
english, 2019